EY – Pharma’s New Architecture: Where Novel Science Meets AI and Manufacturing Power

This report explores the transformation of the pharmaceutical industry through the integration of novel science, AI, and manufacturing capabilities.

It highlights the shift from traditional siloed approaches to a new architecture that combines biological innovation, AI-driven decision making, and digitally enabled manufacturing. The report emphasizes India's emerging role as a global hub for integrated pharma innovation and stresses the importance of harmonizing science with technology to accelerate development and commercialization.